Tak Paul Peter 4
4 · Candel Therapeutics, Inc. · Filed Nov 30, 2023
Insider Transaction Report
Form 4
Tak Paul Peter
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
2023-11-28$0.90/sh−43,443$39,099→ 373,556 total
Footnotes (1)
- [F1]These shares were withheld by the Issuer to satisfy tax withholding obligations associated with the vesting and settlement of restricted stock units.